Aptevo Therapeutics Inc. — Director's Dealing 2018

Mar 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2018-03-09

Reporting Person: White Marvin L (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-09	Employee Stock Options (Right to Buy)	$3.13	A	151600	Acquired	2028-03-09	Common Stock (151600)	Direct

Footnotes

F1: On March 9, 2018, the reporting person was granted 151,600 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date.